{"nct_id":"NCT05933577","title":"A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2023-07-19","start_date_type":"ACTUAL","primary_completion_date":"2029-10-26","primary_completion_date_type":"ESTIMATED","completion_date":"2030-09-26","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}